Foregen (@foregen) 's Twitter Profile
Foregen

@foregen

Foregen is a non-profit organization founded to research and implement regenerative medical therapies for circumcised males.

ID: 222255876

linkhttp://www.foregen.org calendar_today02-12-2010 22:05:50

3,3K Tweet

3,3K Takipçi

52 Takip Edilen

Foregen (@foregen) 's Twitter Profile Photo

Circumcision can leave lasting emotional and physical scars. That's why we're developing a regenerative solution—because no one's pain should be ignored.

Circumcision can leave lasting emotional and physical scars.
That's why we're developing a regenerative solution—because no one's pain should be ignored.
Foregen (@foregen) 's Twitter Profile Photo

Our community raised an incredible $34,748 for our December match campaign—nearly $10k over our target! With the match, almost $60,000 is now fueling the automation of our bioreactors. This is the foundation for our "bioreactor farm" and clinical scaling. Thank you for your

Our community raised an incredible $34,748 for our December match campaign—nearly $10k over our target!

With the match, almost $60,000 is now fueling the automation of our bioreactors. This is the foundation for our "bioreactor farm" and clinical scaling.

Thank you for your
Foregen (@foregen) 's Twitter Profile Photo

BBC News (UK) This is heartbreaking yet preventable. Non-therapeutic circumcision of minors, regulated or not, creates real emotional and psychological harms. Foregen is developing a regenerative medicine solution to reverse these harms, for those who seek it.

Foregen (@foregen) 's Twitter Profile Photo

Metro This is hearbreaking yet entirely preventable. Non-therapeutic circumcision of minors carries unjustifiable risks and results in lasting physical and psychological harms.

Foregen (@foregen) 's Twitter Profile Photo

HUGE NEWS: We raised $62,959 for our December match campaign! 🎉 We’re automating our bioreactors to build the "bioreactor farm" model. Plus, we’re wrapping Milestone 3 and moving to Milestone 4—the FINAL preclinical stage! Read the full update: foregen.org/commentarium-a…

HUGE NEWS: We raised $62,959 for our December match campaign! 🎉

We’re automating our bioreactors to build the "bioreactor farm" model. Plus, we’re wrapping Milestone 3 and moving to Milestone 4—the FINAL preclinical stage!

Read the full update: foregen.org/commentarium-a…
Foregen (@foregen) 's Twitter Profile Photo

A new lab tour episode is here! Watch William Musa and Ján Kováč discuss the innovative bioreactor technology we are utilizing. youtu.be/lzDnKHxb6d4

Foregen (@foregen) 's Twitter Profile Photo

Pilot recellularization success! We’ve verified the attachment and proliferation of fibroblasts, keratinocytes, and stem cells across 50+ samples using confocal microscopy. 🔬 This proves our scaffolds are non-toxic and ready for new cells. Read more: foregen.org/commentarium-a…

Pilot recellularization success!

We’ve verified the attachment and proliferation of fibroblasts, keratinocytes, and stem cells across 50+ samples using confocal microscopy. 🔬

This proves our scaffolds are non-toxic and ready for new cells.

Read more: foregen.org/commentarium-a…
Foregen (@foregen) 's Twitter Profile Photo

Check out our latest newsletter, where we discuss our successful pilot recellularization test and our latest lab tour video! foregen.org/commentarium-a…

Check out our latest newsletter, where we discuss our successful pilot recellularization test and our latest lab tour video! foregen.org/commentarium-a…
Foregen (@foregen) 's Twitter Profile Photo

HustleBitch Non-therapeutic circumcision for minors is profoundly unethical. That's why we're developing a regenerative medicine solution to reverse the physical and emotional harms of this unneccessary and non-consensual genital surgery.

Foregen (@foregen) 's Twitter Profile Photo

2025 pushed Foregen forward in a big way: real progress in the lab, new peer-reviewed science, and a community that showed up when it mattered most. If you want the clearest picture yet of what we accomplished, read our Year in Review. foregen.org/commentarium-a…